Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...
Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback